Technical Analysis for EXAS - Exact Sciences Corporation

Grade Last Price % Change Price Change
grade B 66.33 -3.62% -2.49
EXAS closed down 3.62 percent on Friday, June 22, 2018, on 6.47 times normal volume.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical EXAS trend table...

Date Alert Name Type % Chg
Jun 22 MACD Bearish Signal Line Cross Bearish 0.00%
Jun 22 Volume Surge Other 0.00%
Jun 22 Wide Bands Range Expansion 0.00%
Jun 22 Down 3 Days in a Row Weakness 0.00%
Jun 22 Down 4 Days in a Row Weakness 0.00%
Jun 21 Multiple of Ten Bearish Other -3.62%
Jun 21 Wide Bands Range Expansion -3.62%
Jun 21 Overbought Stochastic Strength -3.62%
Jun 21 Down 3 Days in a Row Weakness -3.62%
Jun 20 Spinning Top Other -4.33%

Older signals for EXAS ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing diagnostic screening products for the early detection and prevention of colorectal pre-cancer and cancer. The company develops the Cologuard, a non-invasive stool-based DNA colorectal cancer screening test that is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer. Its Cologuard test includes proprietary and patented methods that isolate and analyze the human DNA that are shed into stool every day from the exfoliation of cells that line the colon; and also protein marker to detect blood in the stool, utilizing an antibody-based fecal immunochemical test. The company's stool-based DNA colorectal cancer screening technology also focuses on the inflammatory bowel disease. It has collaboration, license, and purchase agreement with Genzyme Corporation, as well as with Mayo Clinic for developing tests to detect other gastro-intestinal cancers, primarily esophageal and pancreatic cancer. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Is EXAS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 71.6
52 Week Low 33.86
Average Volume 2,396,526
200-Day Moving Average 51.1251
50-Day Moving Average 55.3592
20-Day Moving Average 63.8175
10-Day Moving Average 67.931
Average True Range 2.4543
ADX 48.93
+DI 37.11
-DI 16.41
Chandelier Exit (Long, 3 ATRs ) 64.2371
Chandelier Exit (Short, 3 ATRs ) 58.1229
Upper Bollinger Band 74.2025
Lower Bollinger Band 53.4325
Percent B (%b) 0.62
BandWidth 32.545932
MACD Line 4.164
MACD Signal Line 4.2804
MACD Histogram -0.1164
Fundamentals Value
Market Cap 7.9 Billion
Num Shares 119 Million
EPS -1.29
Price-to-Earnings (P/E) Ratio -51.42
Price-to-Sales 34.69
Price-to-Book 10.86
PEG Ratio -1.87
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 71.16
Resistance 3 (R3) 71.51 70.25 70.36
Resistance 2 (R2) 70.25 69.02 70.08 70.09
Resistance 1 (R1) 68.29 68.26 67.66 67.94 69.82
Pivot Point 67.03 67.03 66.72 66.86 67.03
Support 1 (S1) 65.07 65.80 64.44 64.72 62.84
Support 2 (S2) 63.81 65.04 63.64 62.57
Support 3 (S3) 61.85 63.81 62.31
Support 4 (S4) 61.50